Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 12 | $238,034 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Mar 2024 21:03 | XERS | Xeris Biopharma Holdings Inc | SCHMID JOHN P. | Director | 14 Mar 2024 | Purchase | 4,500 | 2.16 | 9,720 | I |
17 Nov 2023 18:35 | XERS | Xeris Biopharma Holdings Inc | SCHMID JOHN P. | Director | 16 Nov 2023 | Purchase | 6,500 | 1.51 | 9,815 | I |
21 Nov 2023 16:20 | XERS | Xeris Biopharma Holdings Inc | HALKUFF DAWN | Director | 20 Nov 2023 | Purchase | 5,410 | 1.84 | 9,954 | I |
15 Nov 2023 16:13 | XERS | Xeris Biopharma Holdings Inc | PERSKY MARLA | Director | 14 Nov 2023 | Purchase | 6,370 | 1.5789 | 10,058 | I |
29 Nov 2023 16:09 | XERS | Xeris Biopharma Holdings Inc | SHERMAN JEFFREY W | Director | 27 Nov 2023 | Purchase | 5,400 | 1.87 | 10,098 | I |
12 Aug 2024 18:28 | XERS | Xeris Biopharma Holdings Inc | SCHMID JOHN P. | Director | 09 Aug 2024 | Purchase | 4,285 | 2.365 | 10,134 | I |
13 Aug 2024 16:15 | XERS | Xeris Biopharma Holdings Inc | SCHMID JOHN P. | Director | 12 Aug 2024 | Purchase | 4,515 | 2.2474 | 10,147 | I |
10 May 2024 16:04 | XERS | Xeris Biopharma Holdings Inc | SCHMID JOHN P. | Director | 10 May 2024 | Purchase | 5,400 | 1.91 | 10,314 | I |
09 Aug 2023 18:57 | XERS | Xeris Biopharma Holdings Inc | EDICK PAUL R | See Remarks | 09 Aug 2023 | Purchase | 10,000 | 2.3794 | 23,794 | D |
14 Dec 2022 16:11 | XERS | Xeris Biopharma Holdings Inc | EDICK PAUL R | See Remarks | 13 Dec 2022 | Purchase | 20,000 | 1.45 | 29,000 | D |
17 Nov 2023 17:58 | XERS | Xeris Biopharma Holdings Inc | SHANNON JOHN PATRICK JR | See Remarks | 17 Nov 2023 | Purchase | 30,769 | 1.638 | 50,400 | D |
21 Nov 2023 16:16 | XERS | Xeris Biopharma Holdings Inc | PIEPER STEVEN | See Remarks | 20 Nov 2023 | Purchase | 28,000 | 1.95 | 54,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)